Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda

Objectives For the purpose of blocking transmission of Plasmodium falciparum malaria from humans to mosquitoes, a single dose of primaquine is recommended by the WHO as an addition to artemisinin combination therapy. Primaquine clears gametocytes but causes dose-dependent haemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Evidence is needed to inform the optimal dosing of primaquine for malaria elimination programmes and for the purpose of interrupting the spread of artemisinin-resistant malaria. This study investigates the efficacy and safety of reducing doses of primaquine for clearance of gametocytes in participants with normal G6PD status. Methods and analysis In this prospective, four-armed randomised placebo-controlled double-blinded trial, children aged 1–10 years, weighing over 10 kg, with haemoglobin ≥8 g/dl and uncomplicated P falciparum malaria are treated with artemether lumefantrine and randomised to receive a dose of primaquine (0.1, 0.4 or 0.75 mg base/kg) or placebo on the third day of treatment. Participants are followed up for 28 days. Gametocytaemia is measured by quantitative nucleic acid sequence-based analysis on days 0, 2, 3, 7, 10 and 14 with a primary endpoint of the number of days to gametocyte clearance in each treatment arm and secondarily the area under the curve of gametocyte density over time. Analysis is for non-inferiority of efficacy compared to the reference dose, 0.75 mg base/kg. Safety is assessed by pair-wise comparisons of the arithmetic mean (±SD) change in haemoglobin concentration per treatment arm and analysed for superiority to placebo and incidence of adverse events. Ethics and dissemination Approval was obtained from the ethical committees of Makerere University School of Medicine, the Ugandan National Council of Science and Technology and the London School of Hygiene and Tropical Medicine. Results These will be disseminated to inform malaria elimination policy, through peer-reviewed publication and academic presentations.

[1]  W. Hawley,et al.  The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  T. Bousema,et al.  Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions? , 2013, Trends in parasitology.

[3]  L. Luzzatto,et al.  Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common , 2012, Malaria Journal.

[4]  A. Dondorp Editorial Commentary: Single-Dose Primaquine as Gametocytocidal Treatment in Patients With Uncomplicated Falciparum Malaria , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  X. Su,et al.  Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. , 2012, The Lancet. Infectious diseases.

[6]  T. Bousema,et al.  Rationale for short course primaquine in Africa to interrupt malaria transmission , 2012, Malaria Journal.

[7]  P. Garner,et al.  Primaquine for reducing Plasmodium falciparum transmission. , 2012, The Cochrane database of systematic reviews.

[8]  J. Cox,et al.  Novel Vectors of Malaria Parasite in the Western Highlands of Kenya , 2012, Emerging infectious diseases.

[9]  O. Doumbo,et al.  Mosquito Feeding Assays to Determine the Infectiousness of Naturally Infected Plasmodium falciparum Gametocyte Carriers , 2012, PloS one.

[10]  Teun Bousema,et al.  Factors determining the occurrence of submicroscopic malaria infections and their relevance for control , 2012, Nature Communications.

[11]  S. Hoffman,et al.  Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue , 2011, Proceedings of the National Academy of Sciences.

[12]  T. Wellems,et al.  The threat of artemisinin-resistant malaria. , 2011, The New England journal of medicine.

[13]  T. Déirdre Hollingsworth,et al.  The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria , 2011, PloS one.

[14]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[15]  M. Riehle,et al.  A Cryptic Subgroup of Anopheles gambiae Is Highly Susceptible to Human Malaria Parasites , 2011, Science.

[16]  Ogobara K. Doumbo,et al.  A Research Agenda to Underpin Malaria Eradication , 2011, PLoS medicine.

[17]  Elizabeth Ashley,et al.  Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial , 2010, The Lancet. Infectious diseases.

[18]  Wes Hinsley,et al.  Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies , 2010, PLoS medicine.

[19]  T. Bousema,et al.  In Tanzania, Hemolysis after a Single Dose of Primaquine Coadministered with an Artemisinin Is Not Restricted to Glucose-6-Phosphate Dehydrogenase-Deficient (G6PD A−) Individuals , 2010, Antimicrobial Agents and Chemotherapy.

[20]  F. Ou,et al.  Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine , 2010, Malaria Journal.

[21]  T. Bousema,et al.  Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission , 2009, PloS one.

[22]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[23]  I. Versteeg,et al.  A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya , 2008, Malaria Journal.

[24]  A. Ghani,et al.  Modelling the Impact of Artemisinin Combination Therapy and Long-Acting Treatments on Malaria Transmission Intensity , 2008, PLoS medicine.

[25]  H. Babiker,et al.  A Randomized Open-Label Trial of Artesunate- Sulfadoxine-Pyrimethamine with or without Primaquine for Elimination of Sub-Microscopic P. falciparum Parasitaemia and Gametocyte Carriage in Eastern Sudan , 2007, PloS one.

[26]  T. Bousema,et al.  Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate , 2007, PloS one.

[27]  Ernest Beutler,et al.  Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. , 2007, The American journal of tropical medicine and hygiene.

[28]  B. Tekwani,et al.  8-Aminoquinolines: future role as antiprotozoal drugs , 2006, Current opinion in infectious diseases.

[29]  A. Muñoz,et al.  Use of area under the curve to characterize transmission potential after antimalarial treatment. , 2006, The American journal of tropical medicine and hygiene.

[30]  Umberto D'Alessandro,et al.  Variation in malaria transmission intensity in seven sites throughout Uganda. , 2006, The American journal of tropical medicine and hygiene.

[31]  R. Hallett,et al.  Chloroquine/Sulphadoxine-Pyrimethamine for Gambian Children with Malaria: Transmission to Mosquitoes of Multidrug-Resistant Plasmodium falciparum , 2006, PLoS clinical trials.

[32]  Petra Schneider,et al.  Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. , 2006, The Journal of infectious diseases.

[33]  T. Bousema,et al.  (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. , 2006, International journal for parasitology.

[34]  H. Babiker,et al.  Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  M. Coosemans,et al.  Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control , 2005, Tropical medicine & international health : TM & IH.

[36]  Petra Schneider,et al.  Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. , 2004, Molecular and biochemical parasitology.

[37]  A. Talman,et al.  Gametocytogenesis : the puberty of Plasmodium falciparum , 2004, Malaria Journal.

[38]  Nicholas J. White,et al.  Activities of Artesunate and Primaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria , 2004, Antimicrobial Agents and Chemotherapy.

[39]  C. Drakeley,et al.  Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short‐lived reduction in infectiousness for mosquitoes , 2004, Tropical medicine & international health : TM & IH.

[40]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[41]  B. Hall,et al.  A Model for Sequestration of the Transmission Stages of Plasmodium falciparum: Adhesion of Gametocyte-Infected Erythrocytes to Human Bone Marrow Cells , 2000, Infection and Immunity.

[42]  W. Metzger,et al.  Reliability of malaria microscopy in epidemiological studies: results of quality control , 2000, Tropical medicine & international health : TM & IH.

[43]  P. Ambroise‐Thomas,et al.  High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. , 1993, The American journal of tropical medicine and hygiene.

[44]  P. Reeve,et al.  Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. , 1992, The Journal of tropical medicine and hygiene.

[45]  A. Kaneko,et al.  Gametocytocidal effect of primaquine in a chemotherapeutic malaria control trial in North Sumatra, Indonesia. , 1989, The Southeast Asian journal of tropical medicine and public health.

[46]  T. Harinasuta,et al.  Effect of a single dose of primaquine on a Thai strain of Plasmodium falciparum. , 1980, The Southeast Asian journal of tropical medicine and public health.

[47]  R. Sinden,et al.  Plasmodium falciparum gametocytes: their longevity and infectivity , 1977, Parasitology.

[48]  Margaret Mitchell,et al.  Brief Report: Special Modifications of the Fluorescent Screening Method for Glucose-6-Phosphate Dehydrogenase Deficiency , 1968 .

[49]  L. Charles Observations on the haemolytic effect of primaquine in 100 Ghanaian children. , 1960, Annals of tropical medicine and parasitology.

[50]  M. D. Young,et al.  The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases. , 1956, American journal of hygiene.

[51]  M. Mackerras,et al.  Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum. , 1949, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[52]  A. Robertson,et al.  The Structure and Development of Plasmodium falciparum Gametocytes in the Internal Organs and Peripheral Circulation. , 1935 .

[53]  Andrea K. Knittel,et al.  Open Access RESEARCH , 2010 .

[54]  M. Laufer Monitoring antimalarial drug efficacy: Current challenges , 2009, Current infectious disease reports.

[55]  Organización Mundial de la Salud Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations , 2008 .

[56]  A. Lensen,et al.  Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. , 1999, Experimental parasitology.

[57]  M. Smalley,et al.  The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian children. , 1981, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[58]  E. Beutler,et al.  Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. , 1968, Blood.

[59]  K. Rieckmann,et al.  Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. , 1968, Bulletin of the World Health Organization.

[60]  R. W. Burgess,et al.  The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum. , 1961, Bulletin of the World Health Organization.

[61]  A. Gunders The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falcipara (Plasmodium falciparum) in Liberia. , 1961, Bulletin of the World Health Organization.

[62]  A. Tarlov,et al.  Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. , 1960, Bulletin of the World Health Organization.

[63]  J. W. Field,et al.  The Microscopic Diagnosis of Human Malaria. II. A Morphological Study of the Erythroeytic Parasites. , 1956 .

[64]  J. W. Field,et al.  A morphological study of the erythrocytic parasites , 1956 .